Dr. Deena Rose Altman, MD

Dr. Altman practices at The Mount Sinai Hospital in New York, New York, part of Mount Sinai Health System.

Dr. Altman's NPI, 1770781171, was assigned on July 6, 2007. Dr. Altman graduated from Ben Gurion University of the Negev in 2007. Dr. Altman holds New York license 257814.

Dr. Altman's primary practice is The Mount Sinai Hospital, at One Gustave L Levy Place, New York, NY 10029 in New York County. The practice phone is (212) 241-7981. Dr. Altman also practices at The Mount Sinai Hospital, 1 Gustave L Levy Pl, New York, NY 10029.

Dr. Altman's primary practice is The Mount Sinai Hospital in New York, New York, part of Mount Sinai Health System. The medical group on file is Mount Sinai Institute for Liver Medicine. Dmand AI also links Dr. Altman to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Altman practices, 2 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Altman's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Altman is licensed in New York.

CMS data shows 217 Medicare services from Dr. Altman across 3 procedure codes in 2024, for 97 Medicare patients. Medicare paid $23,608 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 97 Medicare patients who saw Dr. Altman in 2024. The largest group is 65 to 74, with 37 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 62% are also on Medicaid. Their average risk score is 4.08, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Altman's median patient age at 56, with 36% women.

In 2024, Dr. Altman wrote 1,327 Medicare Part D claims for 34 patients. 67% of them were for generic drugs. CMS names the drug for 1,085 of them, across 47 drugs with 11 or more claims each, at $1,095,590 in total drug cost. In 2023, CMS named 880 claims across 37 drugs.

Dr. Altman accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 30 papers to Dr. Altman, published from 2010 to 2024. 2020 was the busiest year, with 5. The most frequent topics are Methicillin-Resistant Staphylococcus aureus, Staphylococcal Infections and Bacteremia. Dr. Altman has published most often in Case Rep Infect Dis. Dr. Altman's most frequent co-authors are Bo Shopsin, MD, PhD, Ana Beatriz Berbel Caban, MD and Judith Ann Aberg, MD.

CMS Open Payments shows 5 general payments to Dr. Altman from 3 drug and device companies from 2019 to 2021. Consulting fees make up the largest share, 80% of the total. Becton, Dickinson and Company paid the most, $292.

Dr. Altman graduated from Ben Gurion University of the Negev in 2007.